These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2230649)

  • 1. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    J Exp Med; 1990 Nov; 172(5):1367-75. PubMed ID: 2230649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    Eur J Immunol; 1990 Sep; 20(9):2057-66. PubMed ID: 2209703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-restricted lymphoproliferation in autoimmune lpr mice.
    Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T
    Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cells.
    Tiberghien F; Pflumio F; Kuntz L; Loor F
    Immunology; 1993 May; 79(1):158-66. PubMed ID: 8099566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene.
    Sobel ES; Kakkanaiah VN; Cohen PL; Eisenberg RA
    Int Immunol; 1993 Oct; 5(10):1275-8. PubMed ID: 7505611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus.
    Montecino-Rodriguez EM; Loor F
    Immunology; 1991 Sep; 74(1):127-31. PubMed ID: 1682243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gld and lpr hematopoietic cell transfers: common and different serological features of the C57BL/6 chimeras.
    Velin D; Goettelfinger P; Froidevaux S; Loor F
    Cell Immunol; 1993 May; 148(2):331-45. PubMed ID: 8098670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Yaa mutation induces the development of autoimmunity in mice heterozygous for the gld (generalized lymphadenopathy disease) mutation.
    Rosenblatt N; Hartmann KU; Loor F
    Cell Immunol; 1994 Jul; 156(2):519-28. PubMed ID: 8025960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of the gld syndrome in double congenic nude lpr mice.
    Froidevaux S; Rosenblatt N; Loor F
    Autoimmunity; 1992; 12(2):107-15. PubMed ID: 1617109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenopathy induced by the cooperation between lprcg and gld genes is of lpr but not of gld phenotype.
    Matsuzawa A; Katagiri T; Ogata Y; Kominami R; Kimura M
    Eur J Immunol; 1994 Jul; 24(7):1714-6. PubMed ID: 8026532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel origin of lpr and gld cells and possible implications in autoimmunity.
    Singer PA; Theofilopoulos AN
    J Autoimmun; 1990 Apr; 3(2):123-35. PubMed ID: 2187451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus.
    Matsumoto K; Yoshikai Y; Asano T; Himeno K; Iwasaki A; Nomoto K
    J Exp Med; 1991 Jan; 173(1):127-36. PubMed ID: 1670637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
    Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
    J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.
    Roths JB; Murphy ED; Eicher EM
    J Exp Med; 1984 Jan; 159(1):1-20. PubMed ID: 6693832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cell transfer of autoimmune diseases in a MRL strain of mice with a deficit in functional Fas ligand: dissociation of arteritis from glomerulonephritis.
    Ito MR; Ono M; Itoh J; Nose M
    Pathol Int; 2003 Aug; 53(8):518-24. PubMed ID: 12895230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.
    Cohen PL; Eisenberg RA
    Annu Rev Immunol; 1991; 9():243-69. PubMed ID: 1910678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.